Even effective drugs require adequately powered trials: Systemic bevacizumab in hereditary hemorrhagic telangiectasia.
Even effective drugs require adequately powered trials: Systemic bevacizumab in hereditary hemorrhagic telangiectasia.
复制标题
即使有效的药物也需要足够有力的试验：全身性贝伐单抗治疗遗传性出血性毛细血管扩张症。
DOI：
10.1111/joim.13713
复制
发表时间：
2023
影响因子：
11.1
通讯作者：
Al-Samkari,Hanny
中科院分区：
文献类型：
--
作者：
Al-Samkari,Hanny
